Will US Supreme Court Come To Teva’s Rescue On ‘Skinny Label’ Battle?

Israeli Firm Petitions For Certiorari Review Of Labelling Carve-Outs Litigation With GSK

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.